Background Invasive fungal infections cause millions of infections annually, but diagnosis
remains challenging. There is an increased need for low-cost, easy to use, highly sensitive …

Introduction Fungal PCR has undergone considerable standardization and, together with
the availability of commercial assays, external quality assessment schemes, and extensive …

Recently, the global emergence of emergomycosis, a systemic fungal infection caused by a
novel dimorphic fungus Emergomyces species has been observed among …

Candida auris is a recently described emerging pathogen in hospital settings. Five genetic
clades have been delineated, with each clade being isolated from specific geographic …

Human histoplasmosis is a mycosis caused by two distinct varieties of a dimorphic fungus:
Histoplasma capsulatum var. capsulatum and H. capsulatum var. duboisii. In Europe, it is …

Histoplasmosis is a global fungal disease that has a high prevalence especially in the
Americas caused by diverse species nested within the genus Histoplasma [1]. Other parts of …

Background Histoplasmosis is a common cause of invasive fungal infection in endemic
regions and accurate diagnosis is difficult without direct tissue culture or pathology. Indirect …

Background In‐house real‐time PCR (qPCR) is increasingly used to diagnose the so‐called
endemic mycoses as commercial assays are not widely available. Objectives To compare …

Abstract Purpose of Review Histoplasmosis remains a challenging infection in solid organ
transplantation. This review provides a topic update with emphasis on the changing …

Invasive fungal diseases (IFDs) comprise a growing healthcare burden, especially given the
expanding population of immunocompromised hosts. Early diagnosis of IFDs is required to …